TG THERAPEUTICS, INC. (TGTX) › Weighted Average Diluted SharesTG THERAPEUTICS, INC. (TGTX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 115.33M2021-12-31: 132.22M2022-12-31: 135.41M2023-12-31: 148.51M2024-12-31: 160.34M2025-12-31: 161.41M161.41M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31161.41M+0.7%2026-02-27From 2025-01-012024-12-31160.34M+8.0%2026-02-27From 2024-01-012023-12-31148.51M+9.7%2026-02-27From 2023-01-012022-12-31135.41M+2.4%2025-03-03From 2022-01-012021-12-31132.22M+14.6%2024-02-29From 2021-01-012020-12-31115.33M—2023-03-01From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)